Literature DB >> 15723384

Pharmacotherapy of adult ADHD.

William W Dodson1.   

Abstract

Although attention deficit hyperactivity disorder (ADHD) has been officially recognized as persisting into adulthood for more than 25 years, only recently has the condition been studied in adults. There is great syndromatic continuity between childhood and adult ADHD, and thus much of the medication management of adults with ADHD can be based on the experience gained from treating children and adolescents. Stimulant medications remain the treatment of choice and are generally as effective in adults as they are in children. Several extended-release delivery systems that improve convenience and compliance have become available. Several second-line medications are also reviewed. The medications must be fine-tuned to the needs of the individual patient in regard to the dose and timing of dose that achieve optimal therapeutic benefit. Medication adjustment must be done by trial and error because no parameter yet identified predicts the molecule or dose that will provide optimal performance. Copyright 2005 Wiley Periodicals, Inc

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723384     DOI: 10.1002/jclp.20122

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  14 in total

1.  Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Xavier Castells; Lídia Blanco-Silvente; Ruth Cunill
Journal:  Cochrane Database Syst Rev       Date:  2018-08-09

2.  Externalizing Outcomes of Youth with and without ADHD: Time-Varying Prediction by Parental ADHD and Mediated Effects.

Authors:  Elizabeth Moroney; Irene Tung; Whitney A Brammer; Tara S Peris; Steve S Lee
Journal:  J Abnorm Child Psychol       Date:  2017-04

Review 3.  Exposure to attention deficit hyperactivity disorder medications during pregnancy.

Authors:  Caitlin Humphreys; Facundo Garcia-Bournissen; Shinya Ito; Gideon Koren
Journal:  Can Fam Physician       Date:  2007-07       Impact factor: 3.275

Review 4.  Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.

Authors:  Kim Peterson; Marian S McDonagh; Rongwei Fu
Journal:  Psychopharmacology (Berl)       Date:  2007-11-17       Impact factor: 4.530

5.  Effect of extended-release dexmethylphenidate and mixed amphetamine salts on sleep: a double-blind, randomized, crossover study in youth with attention-deficit hyperactivity disorder.

Authors:  J A Santisteban; M A Stein; L Bergmame; R Gruber
Journal:  CNS Drugs       Date:  2014-09       Impact factor: 5.749

Review 6.  Current status of cognitive-behavioral therapy as a psychosocial treatment for adult attention-deficit/hyperactivity disorder.

Authors:  J Russell Ramsay
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

Review 7.  Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials.

Authors:  Xavier Castells; Ruth Cunill; Dolors Capellà
Journal:  Eur J Clin Pharmacol       Date:  2012-09-16       Impact factor: 2.953

8.  Diagnosing and treating attention-deficit/hyperactivity disorder in adults.

Authors:  Stephen V Faraone; Kevin M Antshel
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

9.  A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD).

Authors:  Gerhardt M Pohl; David L Van Brunt; Wenyu Ye; William W Stoops; Joseph A Johnston
Journal:  BMC Health Serv Res       Date:  2009-06-08       Impact factor: 2.655

10.  Treatment of adult ADHD: is current knowledge useful to clinicians?

Authors:  Terje Torgersen; Bjørn Gjervan; Kirsten Rasmussen
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.